The controversy surrounding surrogate advertisements and celebrity endorsements has intensified significantly as the Food and Drug Administration (FDA) continues its legal scrutiny against Bollywood superstars Shah Rukh Khan, Ajay Devgn, and Tiger Shroff over their association with the 'Vimal Elaichi' brand. The regulatory authority had earlier slapped notices on these prominent actors, questioning their involvement in promoting products that are allegedly linked directly or indirectly to restricted tobacco and pan masala items.
FDA Commissioner Tukaram Mundhe recently addressed a press conference, sharing crucial updates regarding the ongoing investigation. He confirmed that official responses from all three actors have been formally received by the department. Furthermore, responding to specific requests made by the actors, personal hearings were recently conducted for two of them to present their detailed side of the story. While maintaining administrative confidentiality, Mundhe refrained from revealing the names of the specific actors who requested these personal hearings, but emphasized that the legal process is moving forward rigorously.
Administrative authorities and health experts have long pointed out that gutkha, pan masala, and various tobacco-related products have faced a strict legal ban in Maharashtra since 2012. Despite these prohibitions, several corporate entities circumvent the regulations by introducing surrogate products under the guise of mouth fresheners, elaichi, or branded accessories using identical trade names. The FDA's core allegation centers on the premise that these high-profile commercials serve as indirect promotional campaigns for banned tobacco substances, thereby flouting established public health laws and misleading consumers.
The issue gained massive public attention following outspoken remarks by FDA Commissioner Tukaram Mundhe, who strongly criticized the moral grounds of celebrity endorsements. Speaking at a public forum, Mundhe questioned whether these actors would ever have the courage to feed the advertised products to their own children or families. He underscored that preaching one standard while endorsing questionable substances for lucrative financial gains reflects a double standard that is both unethical and legally questionable.
Legal experts suggest that this high-profile case could set a massive precedent for the entertainment and advertising industry across India. As superstars like Ajay Devgn and Shah Rukh Khan manage their heavy professional commitments, including upcoming theatrical releases, this regulatory battle serves as a stern warning regarding celebrity accountability. The public and legal observers now await the final outcome of the FDA's investigation to see how stricter enforcement against surrogate advertising will reshape brand endorsements in the country.
